Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
MousePhenodecreased long bone epiphyseal plate size

MBTPS2 CTSL IRS1

1.29e-0544153MP:0006396
MousePhenoabnormal long bone epiphyseal plate morphology

MBTPS2 CTSL IRS1 CHST11

2.72e-05172154MP:0003055
MousePhenoabnormal epiphyseal plate morphology

MBTPS2 CTSL IRS1 CHST11

3.62e-05185154MP:0006395
Pubmed

Differential patterning of genes involved in serotonin metabolism and transport in extra-embryonic tissues of the mouse.

CTSL DDC

1.90e-051121227238716
Pubmed

Pellino-2 in nonimmune cells: novel interaction partners and intracellular localization.

MYO10 IRS1

3.15e-051421234674267
Pubmed

Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling.

SLC24A2 CHST11 SMYD2

5.26e-0426521319240061
CytobandEnsembl 112 genes in cytogenetic band chrXp22

MBTPS2 MAGEB17

5.79e-03250212chrXp22
GeneFamilyPleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing

MYO10 IRS1

1.23e-02206152682
CoexpressionGSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP

MBTPS2 PRXL2A MYO10 EHD4

1.78e-05200214M6262
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A

ABCF2 CHST11 DGCR8 IER2

2.27e-051852145585_DN
DrugKetanserin

DDC IRS1

1.52e-0420212ctd:D007650
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

4.52e-041652136085_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

4.52e-041652132835_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

4.60e-041662132247_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

4.76e-041682136820_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

POGK IRS1 DGCR8

4.93e-041702131050_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.01e-041712137407_DN
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA

POGK IRS1 DGCR8

5.01e-041712131000_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.01e-041712134954_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.01e-041712135441_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.10e-041722137179_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.10e-041722133428_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA

POGK IRS1 DGCR8

5.10e-041722131072_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.18e-041732135336_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.18e-041732133243_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.27e-041742133462_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.27e-041742131659_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.27e-041742136579_DN
DrugHC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

POGK IRS1 DGCR8

5.27e-04174213909_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.27e-041742135693_DN
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.27e-041742135580_DN
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA

POGK IRS1 DGCR8

5.36e-041752131058_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA

POGK IRS1 DGCR8

5.36e-041752131014_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.45e-041762136932_DN
Drugtrichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA

POGK IRS1 DGCR8

5.45e-04176213981_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.54e-041772136551_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.63e-041782134710_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.63e-041782131471_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

POGK IRS1 DGCR8

5.63e-041782131112_DN
Drugtrichostatin A; Down 200; 0.1uM; MCF7; HG-U133A

POGK IRS1 DGCR8

5.73e-04179213332_DN
Drugscriptaid; Down 200; 10uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.73e-041792136901_DN
Drugtrichostatin A; Down 200; 0.1uM; MCF7; HG-U133A

ABCF2 POGK IRS1

5.73e-04179213331_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.73e-041792136910_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.82e-041802135511_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.91e-041812133643_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

POGK IRS1 DGCR8

5.91e-041812137005_DN
DrugIohexol [66108-95-0]; Down 200; 4.8uM; HL60; HT_HG-U133A

MBTPS2 ABCF2 TTLL5

6.60e-041882132461_DN
Drug17-AAG; Down 200; 1uM; HL60; HT_HG-U133A

ABCF2 TTLL5 DGCR8

6.81e-041902136177_DN
DrugEthopropazine hydrochloride [1094-08-2]; Down 200; 11.4uM; MCF7; HT_HG-U133A

ABCF2 TTLL5 DGCR8

6.81e-041902135296_DN
Drug17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA

TTLL5 DGCR8 IER2

6.91e-04191213998_DN
DrugMefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; PC3; HT_HG-U133A

ABCF2 TTLL5 DGCR8

6.91e-041912132048_DN
DrugRilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A

ABCF2 CHST11 DGCR8

7.02e-041922136512_UP
DrugPuromycin Aminonucleoside

CTSL DDC CHST11

7.02e-04192213ctd:D011692
DrugLabetalol hydrochloride [32780-64-6]; Down 200; 11uM; MCF7; HT_HG-U133A

MYO10 ABCF2 DGCR8

7.02e-041922136809_DN
DrugTranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A

MBTPS2 ABCF2 TTLL5

7.02e-041922132101_DN
DrugLY 294002; Down 200; 10uM; PC3; HT_HG-U133A

ABCF2 CHST11 TTLL5

7.02e-041922134463_DN
Drug17-AAG; Down 200; 1uM; HL60; HT_HG-U133A

ABCF2 IER2 EHD4

7.02e-041922132666_DN
DrugNorethindrone [68-22-4]; Up 200; 13.4uM; HL60; HT_HG-U133A

SLC24A2 IRS1 DGCR8

7.02e-041922132383_UP
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; HL60; HT_HG-U133A

MYO10 IRS1 TTLL5

7.13e-041932132477_DN
Druggeldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A

IRS1 DGCR8 IER2

7.13e-041932136946_DN
DrugParoxetine

IRS1 HCRTR1

7.15e-0443212ctd:D017374
Drug0173570-0000 [211245-44-2]; Down 200; 1uM; MCF7; HT_HG-U133A

MBTPS2 ABCF2 TTLL5

7.23e-041942134715_DN
DrugSC 19220; Up 200; 10uM; PC3; HT_HG-U133A

ABCF2 TTLL5 DGCR8

7.23e-041942137065_UP
DrugIpratropium bromide [22254-24-6]; Up 200; 9.8uM; HL60; HG-U133A

MYO10 TTLL5 DGCR8

7.23e-041942131769_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

MBTPS2 POGK IRS1

7.23e-041942135017_DN
Drug15d-PGJ2; Up 200; 10uM; PC3; HG-U133A

ABCF2 CHST11 DGCR8

7.23e-04194213446_UP
DrugAndrosterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A

MBTPS2 CHST11 TTLL5

7.23e-041942132650_DN
DrugKhellin [82-02-0]; Down 200; 15.4uM; HL60; HG-U133A

CTSL ABCF2 POGK

7.34e-041952132004_DN
DrugSC-560; Down 200; 10uM; MCF7; HT_HG-U133A

CHST11 TTLL5 DGCR8

7.34e-041952136870_DN
DrugAzlocillin sodium salt [37091-65-9]; Down 200; 8.2uM; HL60; HT_HG-U133A

MYO10 ABCF2 DGCR8

7.34e-041952132727_DN
DrugCholecalciferol [67-97-0]; Down 200; 10.4uM; HL60; HT_HG-U133A

MBTPS2 ABCF2 DGCR8

7.45e-041962132436_DN
DrugTetracaone hydrochloride [136-47-0]; Down 200; 13.2uM; MCF7; HT_HG-U133A

ABCF2 TTLL5 DGCR8

7.45e-041962132888_DN
DrugAllantoin [97-59-6]; Up 200; 25.2uM; PC3; HT_HG-U133A

ABCF2 TTLL5 DGCR8

7.45e-041962135052_UP
DrugOxybenzone [131-57-7]; Down 200; 17.6uM; PC3; HT_HG-U133A

ABCF2 TTLL5 DGCR8

7.45e-041962136309_DN
DrugVigabatrin [60643-86-9]; Down 200; 31uM; HL60; HT_HG-U133A

ABCF2 IRS1 TTLL5

7.56e-041972132452_DN
DrugViomycin sulfate [37883-00-4]; Down 200; 5.2uM; HL60; HT_HG-U133A

ABCF2 IRS1 TTLL5

7.56e-041972132979_DN
DrugCinnarizine [298-57-7]; Up 200; 10.8uM; HL60; HG-U133A

MBTPS2 ABCF2 DGCR8

7.56e-041972131558_UP
Drughaloperidol; Down 200; 10uM; MCF7; HT_HG-U133A

MYO10 ABCF2 TTLL5

7.56e-041972136960_DN
DrugPNU-0293363 [326823-19-2]; Up 200; 10uM; PC3; HT_HG-U133A

ABCF2 TTLL5 DGCR8

7.56e-041972136563_UP
DrugStachydrine hydrochloride; Down 200; 22.2uM; MCF7; HT_HG-U133A

ABCF2 TTLL5 DGCR8

7.56e-041972136805_DN
DrugHesperetin [520-33-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A

MBTPS2 CHST11 DGCR8

7.56e-041972135350_DN
DrugCefotiam hydrochloride; Down 200; 7.2uM; MCF7; HT_HG-U133A

MYO10 DGCR8 IER2

7.56e-041972135361_DN
DrugAmikacin hydrate [37517-28-5]; Up 200; 6.6uM; MCF7; HT_HG-U133A

MYO10 CHST11 DGCR8

7.56e-041972135314_UP
DrugNimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A

ABCF2 TTLL5 DGCR8

7.56e-041972132275_DN
DrugSulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; HL60; HT_HG-U133A

MBTPS2 CTSL ABCF2

7.68e-041982132560_DN
DrugTriamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A

ABCF2 CHST11 DGCR8

7.68e-041982137307_DN
Druggenistein; Down 200; 10uM; PC3; HT_HG-U133A

ABCF2 TTLL5 DGCR8

7.68e-041982131235_DN
DrugMebendazole [31431-39-7]; Down 200; 13.6uM; PC3; HT_HG-U133A

ABCF2 TTLL5 DGCR8

7.68e-041982137370_DN
DrugEtofylline [519-37-9]; Down 200; 17.8uM; MCF7; HT_HG-U133A

MYO10 ABCF2 DGCR8

7.68e-041982132256_DN
DrugAG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A

ABCF2 TTLL5 DGCR8

7.79e-041992135949_DN
DrugVidarabine [5536-17-4]; Down 200; 15uM; HL60; HT_HG-U133A

MYO10 IRS1 DGCR8

7.79e-041992132706_DN
DrugRiluzole hydrochloride; Down 200; 14.8uM; PC3; HT_HG-U133A

ABCF2 TTLL5 DGCR8

7.79e-041992137365_DN
DrugHexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A

MYO10 CHST11 TTLL5

7.79e-041992136244_DN
DrugCoralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; PC3; HT_HG-U133A

MBTPS2 TTLL5 DGCR8

7.79e-041992136317_UP
DrugDiphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; PC3; HT_HG-U133A

MBTPS2 CHST11 DGCR8

7.79e-041992137318_DN
DrugEvoxine [522-11-2]; Down 200; 11.6uM; PC3; HT_HG-U133A

ABCF2 CHST11 DGCR8

7.79e-041992137380_DN
DrugButacaine [149-16-6]; Up 200; 13uM; MCF7; HT_HG-U133A

ACSM5 TTLL5 DGCR8

7.90e-042002136225_UP
DrugRibavirin [36791-04-5]; Down 200; 16.4uM; MCF7; HT_HG-U133A

MBTPS2 CHST11 TTLL5

7.90e-042002136521_DN
DrugMeglumine [6284-40-8]; Up 200; 20.4uM; HL60; HT_HG-U133A

SLC24A2 ABCF2 DGCR8

7.90e-042002133068_UP
DiseaseDiagnosis, Psychiatric

DDC DGCR8

2.87e-0512202C0376338
DiseaseBehavior Disorders

DDC DGCR8

2.87e-0512202C0004930
DiseaseMental disorders

DDC DGCR8

2.87e-0512202C0004936
DiseaseMental Disorders, Severe

DDC DGCR8

2.87e-0512202C4046029
Diseasenephrotic syndrome (biomarker_via_orthology)

CTSL DDC

1.19e-0424202DOID:1184 (biomarker_via_orthology)
Diseaseprogressive supranuclear palsy

SYDE2 EHD4

2.01e-0431202MONDO_0019037
DiseaseS-warfarin to R-warfarin ratio measurement

SLC24A2 HCRTR1

1.88e-0395202EFO_0803331

Protein segments in the cluster

PeptideGeneStartEntry
MQRKKLKDFSGGWRM

ABCF2

221

Q9UG63
RARMDKDGYFWFMGR

ACSM5

456

Q6NUN0
WGSLLRMYGRESSKM

DGCR8

691

Q8WYQ5
RFRSLKMWFVFRMYG

DDC

356

P20711
KMWFVFRMYGVKGLQ

DDC

361

P20711
MWECLNALGMYKGRK

MAGEB17

221

A8MXT2
RKMMKYWATFARTGN

CES5A

486

Q6NT32
FLYMKGGLMNSWKRR

MYO10

1181

Q9HD67
QLMRVYGALMWSLGK

EHD4

231

Q9H223
KGFKASLGWCRRMMR

POGK

301

Q9P215
YMKMDLGPGRRAAWQ

IRS1

941

P35568
MAMAYFQIFRKLWGR

HCRTR1

231

O43613
RRKARMLYQWFNFGM

MBTPS2

66

O43462
WKMYHSRMQRGGLRL

IER2

16

Q9BTL4
LQKWMYKGRLLSLGM

SYDE2

191

Q5VT97
RSYWNGAKRGYLLMK

LMBRD2

211

Q68DH5
WRMNKILGFIMFGLY

SLC24A2

626

Q9UI40
RKMMFMGFIRLGVWY

PRXL2A

146

Q9BRX8
WGMGGYVKMAKDRRN

CTSL

306

P07711
WKRLMMVLTGRGKYS

CHST11

131

Q9NPF2
VASMWLKLGRLYMGL

SMYD2

381

Q9NRG4
GNKWSMSAMLRYLKQ

TTLL5

291

Q6EMB2